NCT01023295View on ClinicalTrials.gov

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG

fosbretabulin

single dose, intravenous infusion

DRUG

Saline

single dose, intravenous infusion

Trial Locations (5)

Unknown

OXiGENE Investigational Site, Los Angeles

OXiGENE Investigational Site, Hong Kong

OXiGENE Investigational Site, Singapore

OXiGENE Investigational Site, Seoul

OXiGENE Investigational Site, Changhua

Sponsors
All Listed Sponsors
lead

Mateon Therapeutics

INDUSTRY